Feasibility of a blood biomarker cohort study within a memory clinic service
This study demonstrates the feasibility of dementia blood biomarker studies in clinical settings using pragmatic study designs and strategies to mitigate barriers to recruitment. By minimizing exclusion criteria and visit burden, such studies can recruit a diverse and clinically-relevant population.
Authors
- Rosie Watson (ORCID: https://orcid.org/0000-0002-4235-3803)
- L. Churilov
- Nawaf Yassi (ORCID: https://orcid.org/0000-0002-0685-0060)
- Dina LoGiudice (ORCID: https://orcid.org/0000-0002-0391-3898)
- Kai Sin Chin (ORCID: https://orcid.org/0000-0002-3384-3499)
- Oneil G. Bhalala (ORCID: https://orcid.org/0000-0002-4412-7009)
- Sarah Holper (ORCID: https://orcid.org/0000-0003-4257-964X)
- Jian Xiang Ding (ORCID: https://orcid.org/0009-0005-9090-7961)
- Jenny Yu (ORCID: https://orcid.org/0000-0002-2322-4563)
Institutions
- The Royal Melbourne Hospital (AU)
- The University of Melbourne (AU)
- Walter and Eliza Hall Institute of Medical Research (AU)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_100598
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00